{"nct_id":"NCT03519256","title":"A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder","status":"TERMINATED","status_verified_date":"2023-05","start_date":"2018-08-02","start_date_type":"ACTUAL","primary_completion_date":"2022-08-22","primary_completion_date_type":"ACTUAL","completion_date":"2022-08-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}